Billionaire George Soros’ 10 Mid-Cap Stocks With Huge Upside Potential

7. Insmed Incorporated (NASDAQ:INSM)

Soros Fund Management’s Stake Value: $31.4 Million

Number of Hedge Fund Holders: 72

Insmed Incorporated operates as a marketer and developer of therapies for patients with rare and serious diseases. The company’s stock has tripled in less than a year, thanks mainly to the success of its lung disease drug brensocatib. In fact, the stock doubled in a single day back in May last year when the company reported an early-stage success related to its development.

There is reason to believe that brensocatib will continue to drive future returns for the company. It received a Priority Review from the FDA back in February, with a target action date of 12th August 2025. This will significantly reduce the time it takes to bring the drug to the market.

Once the drug eventually becomes approved and available, it will be the only approved medication for bronchiectasis on the market! The condition affects nearly half a million people in the US, with a similar number of sufferers in Europe and Japan combined. Clearly, there’s a lot of potential here and George Soros sees that with his $31.4 million stake in the company. According to the median analyst price target, the stock still has an upside of 39.55%.